Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
electroCoreFRA:43E0 +2.33%58 Days Inventory is 157.31 as of Jun. 2026, which is 31% below its 10-year median of 228.42. GuruFocus rates FRA:43E0 with a GF Score™ of 58/100 and a GF Value™ of €7.81 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, electroCore ranks better than 68.07% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). electroCore's Average Total Inventories for the
three
months ended in Jun. 2026 was €1.91 Mil. electroCore's Cost of Goods Sold for the
three
months ended in Jun. 2026 was €1.11 Mil.
Hence, electroCore's Days Inventory for the
three
months ended in Jun. 2026 was 157.31.
The historical rank and industry rank for electroCore's Days Inventory or its related term are showing as below:
FRA:43E0'
s Days Inventory Range Over the Past 10 Years
Min: 132.18 Med: 228.42 Max: 717.71
Current: 132.18
During the past 10 years, electroCore's highest Days Inventory was 717.71. The lowest was 132.18. And the median was 228.42.
FRA:43E0's Days Inventory is ranked better than 68.07% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 176.445
vs FRA:43E0: 132.18
electroCore's Days Inventory
declined
from Jun. 2025 (159.18) to Jun. 2026 (157.31).
Inventory Turnover measures how fast the company turns over its inventory within a year.
electroCore's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.58.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
electroCore's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.23.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
electroCore's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
electroCore's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
electroCore Days Inventory Related Terms
electroCore Days Inventory Historical Data
* Premium members only.
The historical data trend for electroCore's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:43E0 vs COCH, MDAI, SNWV: Days Inventory Comparison
For the Medical Devices subindustry, electroCore's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
electroCore Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, electroCore's Days Inventory distribution charts can be found below:
* The bar in red indicates where electroCore's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
electroCore (FRA:43E0) has a Days Inventory of 157.31 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on electroCore and its competitors. This is 31% below median its historical median of 228.42. Over the past decade, electroCore's Days Inventory has ranged from 132.18 to 717.71. According to the industry distribution chart, electroCore ranks #251 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 31.9%.
Is electroCore's Days Inventory too high?
electroCore's current Days Inventory of 157.31 is 31% below median its 10-year median of 228.42. Over the past 10 years, this metric has ranged from a low of 132.18 to a high of 717.71. The Medical Devices & Instruments industry median Days Inventory is 176.45. electroCore's value of 157.31 is 10.8% below this industry median. Based on the distribution chart, electroCore ranks #251 out of 786 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, electroCore has a GF Score™ of 58/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does electroCore's Days Inventory compare to COCH and MDAI?
According to the Medical Devices & Instruments industry distribution chart, electroCore ranks #251 out of 786 companies for Days Inventory. This puts electroCore in the upper half of its industry. The industry median Days Inventory is 176.45. electroCore's value of 157.31 is 10.8% below this benchmark. Historically, electroCore's own Days Inventory has ranged from 132.18 to 717.71 over the past decade. While the company's 10-year median is 228.42 vs. the industry median of 176.45, electroCore has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 176.45, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. electroCore's current Days Inventory of 157.31 is 10.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on electroCore and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 176.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. electroCore's current Days Inventory is 157.31, which is 31% below median its own 10-year median of 228.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is electroCore stock overvalued right now?
Based on GuruFocus' analysis, electroCore (FRA:43E0) is currently considered Modestly Overvalued. The stock's GF Value™ is €7.81, compared to a current price of €8.80 — trading 12.7% above its estimated fair value. The current Days Inventory is 157.31, which is 31% below median its 10-year median of 228.42 and 10.8% below the Medical Devices & Instruments industry median of 176.45. electroCore's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For electroCore (FRA:43E0), the current Days Inventory is 157.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is electroCore (FRA:43E0) Overvalued in 2026?
Based on GuruFocus' analysis, electroCore stock appears to be overvalued.
The current stock price of €8.80 is trading 12.7% above its estimated GF Value™ of €7.81.
GuruFocus considers electroCore to be Modestly Overvalued.
Key valuation signals for FRA:43E0:
Days Inventory: 157.31 (31% below median its 10-year median of 228.42)
GF Value™: €7.81 vs. price of €8.80 (12.7% above fair value)
Industry Position: 10.8% below the Medical Devices & Instruments median (#251 of 786)
No single metric tells the full story. See the FRA:43E0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
58GF Score
Get the complete analysis for FRA:43E0
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:43E0 has been successfully added to your 
